Key result
Mechanical circulatory support is useful to preemptively support high-risk patients requiring catheter ablation for hemodynamically unstable ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Mechanical circulatory support is crucial for stabilizing patients with cardiogenic shock due to ventricular arrhythmias and preemptively supporting high-risk patients during catheter ablation.
Refractory unstable ventricular arrhythmias (VA) and electrical storm (ES) are often lifethreatening determining haemodynamic impairment, cardiogenic shock and cardiac arrest. The, patients' mortality in this conditions rate up to 50%. For this reason, restoration and maintenance of sinus rhythm is crucial. Antiarrhythmic drugs are usually the first line option but they may be ineffective and may cause side effects. Catheter ablation (CA) is the treatment of choice for refractory VA in the acute phase and is advisable in all eligible patients to reduce ES recurrence.Acute heart decompensation during CA of complex substrates may occur in 11% of cases and is associated with an increased risk of mortality. Temporary mechanical circulatory support (MCS) may be beneficial in treating life-threatening, haemodynamically non-tolerated VA, providing maintenance of organ perfusion while allowing for an accurate treatment of the precipitating arrhythmia. Veno-arterial ECMO is the preferred rescue MCS modality in patients with ES undergoing CA. However, reported mortality rates in the short-term are high, ranging from 38 to 76%, despite successful CA. Of note, preemptive MCS in a selected high-risk population might reduce the risk of acute heart deterioration and death/transplant during follow-up. The identification of patients at high risk of periprocedural haemodynamic deterioration is a matter of priority, since preemptive MCS in this subpopulation can increase CA safety profile.Large randomized clinical trials comparing different devices and different ablation strategies in the setting of cardiogenic shock and ES are not available; prospective multicentre data on prophylactic MCS before CA in high risk patients are missing too.Arrhythmias with Hemodynamic Instability", with four reviews, reports important aspects of using the MCS during CA in patient with unstable VA.The study of Loardi CM summarizes the features, implantation techniques, and results of current devices used for adult MCS. In particular, the study analyzes in detail all the devices available for MCS both for short-term support (devices used to support ablation procedures) but also devices for long-term support in patients with advanced heart disease as a bridge to cardiac transplantation. This review allows the reader to know in detail all the devices for MCS and their usefulness in the clinical practice.The systematic review and meta-analysis of Shalganov T provides the reader with useful aspects to understand the importance of the ablation procedure for VA in terms of efficacy and safety and, above all, provides an analysis of all the studies that have evaluated the early ablation of VA. In particular, the findings of this study underline the use of early ablation in patients with structural heart disease and recurrent VA with the purpose of reducing ICD shocks, arrhythmic storm and hospitalizations for cardiovascular reasons, without increasing the complications related to the treatment. Spartalis M reported all the studies regarding the use of MCS during CA of VA in patients with cardiogenic shock. The authors stressed the importance to perform an accurate pre-procedural riskstratification of patients before CA of VA. Even when approaching ablation in an evident stable cardiopulmonary status, the majority of complex individuals may subsequently encounter periprocedural abrupt hemodynamic deterioration, which has a significant influence on subjects' mortality. In the lack of contraindications, individuals at high risk for ablation should be safeguarded with prophylactic MCS regardless of the pathophysiology of the cardiovascular disorder, the method devised for ablation, and their hemodynamic condition at the beginning of the procedure. The goals of MCS must be to restore an acceptable circulatory state, facilitate CA and bridge individuals to target therapy for cardiac failure.Finally, De Potter T reported a mini-review focused on the non-invasive neurological monitoring to enhance MCS-assisted VA ablation. By enhancing cardiac output, MCS may facilitate conditions for ventricular mapping during the arrhythmia that would otherwise be incompatible with survival.However, the optimal mean arterial pressure to maintain end-organ perfusion in presence of nonpulsatile flow remains unknown. Near-infrared oxygenation monitoring during MCS provides assessment of critical end-organ perfusion during VA, enabling successful mapping and ablation with the continual assurance of adequate brain oxygenation. A careful monitoring through an electroencephalogram also provides additional information improving the assessment of complete brain recovery after VA termination. This focused review introduces practical case scenarios for such an approach, aiming to allow mapping and ablation of VA while drastically reducing the risk of ischemic brain injury.To summarize, the current Research Topic for Frontiers in Cardiovascular Medicine provides the reader with a comprehensive overview of the importance of MCS during CA of unstable VA.Mechanical circulatory support is an effective treatment of cardiogenic shock due to VA. It allows patient's stabilization when a CA procedure is needed. It is also useful to preemptively support highrisk patients who require a CA of unstable VA and to ensure adequate cerebral perfusion during and after the procedure. An adequate brain oxygenation is crucial during these high-risk procedures to avoid neurological damages and its monitoring should be part of the routine setting during these complex ablations. MCS might be continued in the post procedure phase to wean the patient slowly allowing the heart to recover from stunning related to hemodynamic instability and to the energy delivered with ablation and DC shocks Large randomized clinical trials comparing different devices and different ablation strategies for unstable VAs are needed to improve safety and efficacy in such setting.
No takes yet. Share an insight, caveat, or question.
Monaco et al. (2024) conducted an editorial in Ventricular arrhythmias with hemodynamic instability. Mechanical circulatory support during catheter ablation was evaluated. Mechanical circulatory support is useful to preemptively support high-risk patients requiring catheter ablation for hemodynamically unstable ventricular arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: